Fresenius Medical Care Extracorporeal Alliance Awarded Joint Commission Certification

FMCEA met national standards addressing how staffing firmsdetermine the qualifications and competency of their staff, how theyplace their staff, and the subsequent monitoring of the staff'sperformance.

The Joint Commission certification program was launched in October2004 to offer an independent, comprehensive evaluation of a staffingfirm's abilities to provide competent staffing services.

Dr. Paul Zabetakis, CEO of Fresenius Medical Care ExtracorporealAlliance commented, "We're very proud to receive the JointCommission's Gold Seal of Approval. This certification recognizesFMCEA's dedication to providing hospitals with perfusionists, nurses,and technicians that are dedicated to safe, high-quality patientcare".

Michele Sacco, executive director, Health Care Staffing ServicesCertification, Joint Commission commented: "Health care organizationsthat contract with FMCEA can look to this certification as anassurance that FMCEA demonstrates a commitment to providing andcontinuously improving quality services."

FMCEA provides a comprehensive suite of extracorporeal servicesincluding perfusion, autotransfusion, apheresis, and otherimmunoadsorption therapies to over 400 hospitals across the country.As the leader in cardiovascular perfusion, blood conservation, andtherapeutic blood treatment services, FMCEA provides partner hospitalsa specialized clinical staff with the highest level of skills,continuous leadership training, patient care, and the most currentclinical training available.

Founded in 1951, the Joint Commission seeks to continuouslyimprove the safety and quality of care provided to the public throughthe provision of health care accreditation and related services thatsupport performance improvement in health care organizations. TheJoint Commission evaluates and accredits more than 15,000 health careorganizations and programs in the United States, including more than8,200 hospitals and home care organizations, and more than 6,800 otherhealth care organizations that provide long term care, assistedliving, behavioral health care, laboratory and ambulatory careservices. The Joint Commission also accredits health plans, integrateddelivery networks, and other managed care entities. In addition, theJoint Commission provides certification of disease-specific careprograms and primary stroke centers. An independent, not-for-profitorganization, the Joint Commission is the nation's oldest and largeststandards-setting and accrediting body in health care.

Fresenius Medical Care is the world's largest, integrated providerof products and services for individuals undergoing dialysis becauseof chronic kidney failure, a condition that affects more than1,400,000 individuals worldwide. Through its network of approximately2,000 dialysis clinics in North America, Europe, Latin America,Asia-Pacific and Africa, Fresenius Medical Care provides dialysistreatment to approximately 157,000 patients around the globe.Fresenius Medical Care is also the world's leading provider ofdialysis products such as hemodialysis machines, dialyzers and relateddisposable products.

This release contains forward-looking statements that are subjectto various risks and uncertainties. Actual results could differmaterially from those described in these forward-looking statementsdue to certain factors, including changes in business, economic andcompetitive conditions, regulatory reforms, foreign exchange ratefluctuations, uncertainties in litigation or investigativeproceedings, and the availability of financing. These and other risksand uncertainties are detailed in Fresenius Medical Care AG & Co.KGaA's reports filed with the U.S. Securities and Exchange Commission.Fresenius Medical Care AG & Co. KGaA does not undertake anyresponsibility to update the forward-looking statements in thisrelease.